EU Commission to better define medtech directive scope: borderline and aesthetic issues
This article was originally published in Clinica
One of the European Commission’s key aims in the recast of the medical device directives is to ensure that there is much greater clarity about which products are regulated under the directives and which product areas do not come under their scope. Areas focus include products on the borderline with other directives, as well as implantables or other invasive devices without a medical purpose.
You may also be interested in...
How do the EU’s new MDR cybersecurity guidelines expand on the MDR and fit into the myriad other software-related guidance documents the medtech industry has to consider?
Switzerland’s current economic and trading relationship with the UK is based on its MRA with the EU. So, where does this leave the two countries in trading with one another now each of their relationships with the EU are under threat?
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.